Evidence map›Paper›PMID 34683572›Full record

ArticleMaterials (Basel, Switzerland)2021

Synthesis, Self-Assembly and In Vitro Cellular Uptake Kinetics of Nanosized Drug Carriers Based on Aggregates of Amphiphilic Oligomers of

Pavel P Kulikov, Anna L Luss, Levi C Nelemans, Mikhail I Shtilman, Yaroslav O Mezhuev, Igor A Kuznetsov, Oksana Yu Sizova, Gunna Christiansen, Cristian P Pennisi, Leonid Gurevich

Open access · goldAbstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Materials (Basel, Switzerland), 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed
0.7field-weighted citation impact, top 34% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed, 10 citations in OpenAlex.

  1. Review
  2. Article
  3. Article
  4. Article
  5. Review
  6. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 2 institutions in 2 countries.

Pavel P KulikovDepartment of Biomaterials, D. Mendeleev University of Chemical Technology of Russia, 125047 Moscow, Russia.ORCID 0000-0001-5221-7613
Anna L LussDepartment of Biomaterials, D. Mendeleev University of Chemical Technology of Russia, 125047 Moscow, Russia.
Levi C NelemansDepartment of Materials and Production, Aalborg University, Skjernvej 4A, 9220 Aalborg, Denmark.ORCID 0000-0002-8715-244X
Mikhail I ShtilmanDepartment of Biomaterials, D. Mendeleev University of Chemical Technology of Russia, 125047 Moscow, Russia.
Yaroslav O MezhuevDepartment of Biomaterials, D. Mendeleev University of Chemical Technology of Russia, 125047 Moscow, Russia.
Igor A KuznetsovDepartment of Biomaterials, D. Mendeleev University of Chemical Technology of Russia, 125047 Moscow, Russia.
Oksana Yu SizovaDepartment of Biomaterials, D. Mendeleev University of Chemical Technology of Russia, 125047 Moscow, Russia.
Gunna ChristiansenDepartment of Health Science and Technology, Aalborg University, Fredrik Bajers Vej 3B, 9220 Aalborg, Denmark.
Cristian P PennisiDepartment of Health Science and Technology, Aalborg University, Fredrik Bajers Vej 3B, 9220 Aalborg, Denmark.ORCID 0000-0002-7716-1182
Leonid GurevichDepartment of Materials and Production, Aalborg University, Skjernvej 4A, 9220 Aalborg, Denmark.ORCID 0000-0002-5777-2541
D. Mendeleyev University of Chemical Technology of Russia · RUAalborg University · DK

Funding

Ministry of Science and Higher Education of the Russian Federation Agreement no. 075-15-2020-792, unique contract identifier RF ---- 190220X0031
6 · The paper itself

Abstract

Development of nanocarrier-based drug delivery systems is a major breakthrough in pharmacology, promising targeted delivery and reduction in drug toxicity. On the cellular level, encapsulation of a drug substantially affects the endocytic processes due to nanocarrier-membrane interaction. In this study we synthesized and characterized nanocarriers assembled from amphiphilic oligomers of

Indexed as

drug deliveryendocytosisnanocarriers

Identifiers

PMID34683572
PMCPMC8538878
OpenAlexW3207578895

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.